<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03352609</url>
  </required_header>
  <id_info>
    <org_study_id>00070449</org_study_id>
    <nct_id>NCT03352609</nct_id>
  </id_info>
  <brief_title>Accelerated rTMS for the Reduction of Nicotine Craving</brief_title>
  <official_title>Accelerated Repetitive Transcranial Magnetic Stimulation (rTMS) of the Dorsolateral Prefrontal Cortex for the Reduction of Craving in Nicotine Dependent Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose if this study is to determine if five treatments of repetitive transcranial
      magnetic stimulation (rTMS) can reduce craving for cigarettes in smokers. rTMS uses magnetic
      pulses to stimulate the brain and is currently approved for the treatment of major depressive
      disorder.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, double blind, control</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Randomized double blind control using a sham rTMS system</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Tolerability measured by percent of participants completing the rTMS course</measure>
    <time_frame>1 day (single visit)</time_frame>
    <description>Percent of participants completing the 5 session rTMS course. Hypothesize &gt;75% of participants will complete the 5 treatments.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Decrease in cue induced nicotine craving</measure>
    <time_frame>During the one day visit</time_frame>
    <description>Hypothesize that participants receiving active rTMS will have a greater decrease in cue induced nicotine craving when compared to those in the sham group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduce in self reported smoking</measure>
    <time_frame>1 week and 2 weeks after rTMS</time_frame>
    <description>An exploratory outcome will be the determination if participants receiving active rTMS report decreased levels of smoking 1 week and 2 weeks after rTMS course.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Nicotine Use Disorder</condition>
  <condition>Nicotine Dependence</condition>
  <arm_group>
    <arm_group_label>Active rTMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 sessions of rTMS delivered with MagPro (MagVenture) double blind rTMS system delivered at 110% of resting motor threshold with 3000 pulses of 10hz stimulation (5s on, 10s off) per session.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>5 session of sham rTMS delivered with Magpro (MagVenture) double blind rTMS system to mimic active intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active rTMS with MagVenture MagPro double blind rTMS system</intervention_name>
    <description>5 sessions of rTMS delivered with MagPro (MagVenture) double blind rTMS system delivered at 110% of resting motor threshold with 3000 pulses of 10hz stimulation (5s on, 10s off) per session.</description>
    <arm_group_label>Active rTMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham rTMS</intervention_name>
    <description>Double blind MagPro system delivers sham condition by mimicking rTMS sound and delivering skin stimulus via TENS pads</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Outpatient Adults aged 18-70

          -  Cigarette Smokers smoking at least 1 pack (20 cigarettes a day) with current smoking
             status confirmed by exhaled CO reading of &gt;10ppm day of visit.

          -  Ability to provide informed consent

        Exclusion Criteria

          -  Current treatment with varenicline or bupropion

          -  Currently making a smoking quit attempt (not currently smoking).

          -  Current treatment with an antidepressant, anti-convulsant, anxiolytic, antipsychotic
             or mood stabilizer.

          -  Current episode of major depression determined by MINI interview.

          -  Current or past history of schizophrenia, schizoaffective disorder, anorexia nervosa,
             bulimia or bipolar disorder as determined by MINI.

          -  Current daily consumption of alcohol or current alcohol use disorder.

          -  Current substance use disorder except for nicotine or cannabis use disorder.

          -  Currently pregnant or lactating.

          -  Contraindications to rTMS including history of seizure, metal implanted above the
             neck, pacemaker or any brain lesion.

          -  Unstable medical conditions

          -  Suicidal ideation or history of suicide attempt within the last six months.

          -  Inability or unwillingness of subject or legal guardian/representative to give
             informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Friedrich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Friedrich, MD</last_name>
    <phone>843-792-2300</phone>
    <email>friedric@musc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gregory Sahlem, MD</last_name>
    <phone>843-792-2300</phone>
    <email>sahlem@musc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>MUSC Institute of Psychiatry</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Friedrich, MD</last_name>
      <phone>843-792-2300</phone>
      <email>friedric@musc.edu</email>
    </contact>
    <investigator>
      <last_name>David Friedrich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2017</study_first_submitted>
  <study_first_submitted_qc>November 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2017</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>David Friedrich</investigator_full_name>
    <investigator_title>Resident Physician</investigator_title>
  </responsible_party>
  <keyword>TMS</keyword>
  <keyword>rTMS</keyword>
  <keyword>Transcranial Magnetic Stimulation</keyword>
  <keyword>Smoking</keyword>
  <keyword>Nicotine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

